Here, we found that SIRT3 protein levels were significantly negatively associated with acetylated K88 MTHFD2 in our colorectal tumor tissues, which suggested that inhibitors of SIRT3 or MTHFD2 might be an attractive drug to combinate with cisplatin for colorectal cancer treatment. Here, SIRT3 is linked to colorectal neoplasm.